JP2020516689A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020516689A5 JP2020516689A5 JP2020506132A JP2020506132A JP2020516689A5 JP 2020516689 A5 JP2020516689 A5 JP 2020516689A5 JP 2020506132 A JP2020506132 A JP 2020506132A JP 2020506132 A JP2020506132 A JP 2020506132A JP 2020516689 A5 JP2020516689 A5 JP 2020516689A5
- Authority
- JP
- Japan
- Prior art keywords
- subject
- pharmaceutical composition
- composition according
- solvate
- pazopanib
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762486232P | 2017-04-17 | 2017-04-17 | |
| US62/486,232 | 2017-04-17 | ||
| PCT/US2018/027980 WO2018195084A1 (en) | 2017-04-17 | 2018-04-17 | Compounds, compositions and methods of treating or preventing acute lung injury |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020516689A JP2020516689A (ja) | 2020-06-11 |
| JP2020516689A5 true JP2020516689A5 (enExample) | 2021-05-06 |
| JP7108018B2 JP7108018B2 (ja) | 2022-07-27 |
Family
ID=63856399
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020506132A Active JP7108018B2 (ja) | 2017-04-17 | 2018-04-17 | 急性肺傷害を処置または予防する化合物、組成物および方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US11166953B2 (enExample) |
| EP (1) | EP3612184B1 (enExample) |
| JP (1) | JP7108018B2 (enExample) |
| CN (1) | CN110753546B (enExample) |
| CA (1) | CA3060247A1 (enExample) |
| IL (1) | IL270070B2 (enExample) |
| WO (1) | WO2018195084A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2020386436A1 (en) * | 2019-11-20 | 2022-05-26 | Yale University | Compounds, compositions, and methods for treating ischemia-reperfusion injury and/or lung injury |
| CN113350351A (zh) * | 2020-03-13 | 2021-09-07 | 青晓制药公司 | 帕唑帕尼的应用、药物组合物、注射液及制备方法和应用 |
| US20230181582A1 (en) * | 2020-05-22 | 2023-06-15 | Qx Therapeutics Inc. | Compositions and methods for treating lung injuries associated with viral infections |
| CN113624978B (zh) * | 2021-04-06 | 2023-09-19 | 四川大学华西医院 | 通过检测肺泡灌洗液及血清白蛋白来评估急性呼吸窘迫综合征/急性肺损伤及预后的试剂盒 |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5007790A (en) | 1989-04-11 | 1991-04-16 | Depomed Systems, Inc. | Sustained-release oral drug dosage form |
| US5582837A (en) | 1992-03-25 | 1996-12-10 | Depomed, Inc. | Alkyl-substituted cellulose-based sustained-release oral drug dosage forms |
| JPH07507059A (ja) | 1992-03-25 | 1995-08-03 | デポムド システムズ，インコーポレイテッド | アルキル置換セルロースをベースとする持続放出性経口薬剤投与剤形 |
| AU3290397A (en) | 1996-06-10 | 1998-01-07 | Depomed, Inc. | Gastric-retentive oral controlled drug delivery system with enhanced retention properties |
| US5972389A (en) | 1996-09-19 | 1999-10-26 | Depomed, Inc. | Gastric-retentive, oral drug dosage forms for the controlled-release of sparingly soluble drugs and insoluble matter |
| US6635280B2 (en) | 1997-06-06 | 2003-10-21 | Depomed, Inc. | Extending the duration of drug release within the stomach during the fed mode |
| EP0998271B3 (en) | 1997-06-06 | 2014-10-29 | Depomed, Inc. | Gastric-retentive oral drug dosage forms for controlled release of highly soluble drugs |
| AU781718B2 (en) | 1999-11-02 | 2005-06-09 | Depomed, Inc. | Pharmacological inducement of the fed mode for enhanced drug administration to the stomach |
| ATE340563T1 (de) | 2000-02-04 | 2006-10-15 | Depomed Inc | DOSIERUNGSFORM DES TYPS ßHÜLLE UND KERNß MIT EINER WIRKSTOFFFREISETZUNG, DIE SICH DER NULLTEN ORDNUNG ANNÄHERT |
| US6488962B1 (en) | 2000-06-20 | 2002-12-03 | Depomed, Inc. | Tablet shapes to enhance gastric retention of swellable controlled-release oral dosage forms |
| US6451808B1 (en) | 2000-10-17 | 2002-09-17 | Depomed, Inc. | Inhibition of emetic effect of metformin with 5-HT3 receptor antagonists |
| EP1343782B1 (en) | 2000-12-21 | 2009-05-06 | SmithKline Beecham Corporation | Pyrimidineamines as angiogenesis modulators |
| EP1401423A4 (en) | 2001-05-29 | 2006-08-16 | Depomed Dev Ltd | METHOD FOR THE TREATMENT OF GASTROÖSOPHAGEAL REFLUX DISEASE AND NURSING ACID BREAKDOWN |
| TWI312285B (en) | 2001-10-25 | 2009-07-21 | Depomed Inc | Methods of treatment using a gastric retained gabapentin dosage |
| US7413751B2 (en) | 2001-10-25 | 2008-08-19 | Depomed, Inc. | Methods of treatment using a gastric retained losartan dosage |
| CA2409552A1 (en) | 2001-10-25 | 2003-04-25 | Depomed, Inc. | Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract |
| US6723340B2 (en) | 2001-10-25 | 2004-04-20 | Depomed, Inc. | Optimal polymer mixtures for gastric retentive tablets |
| US20030091630A1 (en) | 2001-10-25 | 2003-05-15 | Jenny Louie-Helm | Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data |
| US6682759B2 (en) | 2002-02-01 | 2004-01-27 | Depomed, Inc. | Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs |
| WO2008080153A2 (en) * | 2006-12-22 | 2008-07-03 | The Children's Hospital Of Philadelphia | A novel protein kinase c therapy for the treatment of acute lung injury |
| US20110142837A1 (en) * | 2007-07-20 | 2011-06-16 | Trustees Of The University Of Pennsylvania | Method Of Treating Acute Respiratory Distress Syndrome |
| EP2259844A4 (en) | 2008-03-05 | 2012-02-01 | Vicus Therapeutics Llc | COMPOSITIONS AND METHODS FOR MUCOSITIS AND ONCOLOGICAL THERAPIES |
| US20120107304A1 (en) * | 2010-04-27 | 2012-05-03 | Boehringer Ingelheim International Gmbh | Combination therapy in treatment of oncological and fibrotic diseases |
| JP2014503500A (ja) * | 2010-11-18 | 2014-02-13 | シンタ ファーマスーティカルズ コーポレーション | 低酸素状態に基づく酸素感受性薬剤による治療に適した被験体の事前選択 |
| MY181439A (en) * | 2011-02-28 | 2020-12-22 | Sunshine Lake Pharma Co Ltd | Substituted quinoline compounds and methods of use |
| CN104254249B (zh) * | 2011-10-31 | 2017-02-15 | 诺华股份有限公司 | 帕唑帕尼制剂 |
| WO2013148537A1 (en) * | 2012-03-29 | 2013-10-03 | Ning Xi | Substituted spirobicyclic compounds and methods of use |
| US20150044288A1 (en) | 2013-07-31 | 2015-02-12 | Windward Pharma, Inc. | Aerosol tyrosine kinase inhibitor compounds and uses thereof |
| EP3052480B1 (en) * | 2013-09-30 | 2020-11-11 | The Texas A & M University System | Compositions associated with and methods of managing neutrophil movement |
| KR101636563B1 (ko) * | 2014-01-24 | 2016-07-06 | 주식회사 엘지생명과학 | 급성 폐 손상 및 급성 호흡곤란 증후군의 예방 또는 치료용 조성물 |
| US9718841B2 (en) * | 2014-04-22 | 2017-08-01 | Calitor Sciences, Llc | Bicyclic pyrazolone compounds and methods of use |
-
2018
- 2018-04-17 CN CN201880039957.3A patent/CN110753546B/zh active Active
- 2018-04-17 WO PCT/US2018/027980 patent/WO2018195084A1/en not_active Ceased
- 2018-04-17 CA CA3060247A patent/CA3060247A1/en active Pending
- 2018-04-17 EP EP18787714.7A patent/EP3612184B1/en active Active
- 2018-04-17 IL IL270070A patent/IL270070B2/en unknown
- 2018-04-17 US US16/605,371 patent/US11166953B2/en active Active
- 2018-04-17 JP JP2020506132A patent/JP7108018B2/ja active Active
-
2021
- 2021-10-08 US US17/497,191 patent/US11890283B2/en active Active
-
2023
- 2023-12-22 US US18/394,447 patent/US20240165115A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020516689A5 (enExample) | ||
| HRP20130052T1 (hr) | Lijeäśenje respiratorne bolesti | |
| ATE330589T1 (de) | Pharmazeutische zusammensetzung enthaltend resveratrol zur behandlung von entzündlichen erkrankungen der atemwege | |
| NO20061254L (no) | Farmasoytiske blandinger | |
| JP2010518122A5 (enExample) | ||
| JPH0648958A (ja) | 吸入による非ステロイド系抗炎症剤の抗反応抗喘息活性 | |
| CA2733294A1 (en) | Pharmaceutical combination of a tiotropium salt and ciclesonide | |
| RU2001119990A (ru) | Применение антагониста AT-1 или модулятора рецептора АТ-2 для лечения болезней, связанных с увеличением содержания рецепторов АТ-1 или АТ-2 | |
| JP2005519891A5 (enExample) | ||
| RU2006132036A (ru) | Комбинация и фармацевтический препарат для лечения аллергий и заболеваний дыхательных путей | |
| WO2007109118A3 (en) | RECOMBINANT HUMAN CC 10 (rhCC10) FOR TREATMENT OF RESPIRATORY DISORDERS | |
| JP2019536812A5 (enExample) | ||
| EP2251016B1 (en) | Topical use of hyaluronic acid with filmogenic action for the treatment and prophylaxys of pathologies of the respiratory tract. | |
| RU2003131178A (ru) | Агонисты никотиновых рецепторов для лечения воспалительных заболеваний | |
| JP2007528409A5 (enExample) | ||
| HRP20120286T1 (hr) | Kombinacija antikolinergika i inhibitora fosfodiesteraze tip 4 za liječenje respiratornih bolesti | |
| JP2008533072A5 (enExample) | ||
| JP2008115167A (ja) | トラネキサム酸を含有する気道杯細胞過形成抑制剤 | |
| EA200701077A1 (ru) | Применение конъюгатов липидов при лечении заболеваний | |
| WO2005110052A3 (en) | The use of inhaled gaseous nitric oxide as a mucolytic agent or expectorant | |
| JP2019510788A5 (enExample) | ||
| JPWO2021209739A5 (enExample) | ||
| IL275764B2 (en) | Compositions and methods for the treatment of lung emphysema and other forms of copd | |
| JP6013450B2 (ja) | 慢性閉塞性肺疾患改善剤 | |
| KR20130140672A (ko) | 기침 치료용 카보네이트 유도체 |